Unknown PHASE1 INTERVENTIONAL 1-arm NCT02652351

Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis

Safety and Efficacy Study of Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis

Sponsor: Shenzhen Hornetcorn Bio-technology Company, LTD

Interventions Human umbilical cord mesenchymal stem cells

Updated 7 times since 2017 Last updated: May 20, 2016 Started: Mar 31, 2016 Primary completion: May 31, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Hepatic Cirrhosis and is currently ongoing. Shenzhen Hornetcorn Bio-technology Company, LTD leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Nov 2023 — Jul 2024 [monthly]

Unknown Status PHASE1
Jan 2021 — Nov 2023 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Recruiting PHASE1

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shenzhen Hornetcorn Bio-technology Company, LTD
The Second Hospital University of South China

Data source: Shenzhen Hornetcorn Bio-technology Company, LTD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hengyang, China